Recent Finacing
Recent Raise
Stellular Bio develops off-the-shelf platelet-derived regenerative biologic therapies, with its lead candidate targeting Sjögren’s disease dry eye.
Focus Areas
Recent Investors
Funding round
See the team members at Stellular Bio.
